Rapoport, Stanley I.

Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studies

Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002) · American Journal of Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 532

Kinetics of Neutral Amino Acid Transport Across the Blood‐Brain Barrier

Smith, Q. R., Momma, S., Aoyagi, M., & Rapoport, S. I. (1987) · Journal of Neurochemistry

Barrier Structure and Function StudiesAmino Acid Enzymes and Metabolism

Cited by 454

Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications

Rapoport, S. I. (2000) · Cellular and Molecular Neurobiology

Barrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

Cited by 428

Progression of corpus callosum atrophy in Alzheimer disease

Teipel, S. J., Bayer, W., Alexander, G. E., Zebuhr, Y., Teichberg, D., Kulic, L., Schapiro, M. B., Möller, H.-J., Rapoport, S. I., & Hampel, H. (2002) · Archives of Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 202

Cerebrovascular Permeability Coefficients to Sodium, Potassium, and Chloride

Smith, Q. R., & Rapoport, S. I. (1986) · Journal of Neurochemistry

Barrier Structure and Function StudiesCerebrospinal fluid and hydrocephalus

Cited by 196

Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome

Siarey, R. J., Carlson, E. J., Epstein, C. J., Balbo, A., Rapoport, S. I., & Galdzicki, Z. (1999) · Neuropharmacology

Down syndrome and intellectual disability researchNeuroscience and Neuropharmacology Research

Cited by 184

Regulation of the microenvironment of peripheral nerve: Role of the blood-nerve barrier

Rechthand, E., & Rapoport, S. I. (1987) · Progress in Neurobiology

Barrier Structure and Function StudiesNerve injury and regeneration

Cited by 108

Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain

Ghelardoni, S., Tomita, Y. A., Bell, J. M., Rapoport, S. I., & Bosetti, F. (2004) · Biological Psychiatry

Bipolar Disorder and TreatmentInflammatory mediators and NSAID effects

Cited by 95

Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130

Stübner, S., Schön, T., Padberg, F., Teipel, S. J., Schwarz, M. J., Haslinger, A., Buch, K., Dukoff, R., Lasser, R., Müller, N., et al. (1999) · Neuroscience Letters

Tryptophan and brain disordersCytokine Signaling Pathways and Interactions

Cited by 59

Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging

Primiani, C. T., Ryan, V. H., Rao, J. S., Cam, M. C., Ahn, K., Modi, H. R., & Rapoport, S. I. (2014) · PLoS ONE

Neuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanisms

Cited by 56

Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation

Basselin, M., Kim, H.-W., Chen, M., Ma, K., Rapoport, S. I., Murphy, R. C., & Farias, S. E. (2010) · Journal of Lipid Research

Fatty Acid Research and HealthInflammatory mediators and NSAID effects

Cited by 52

Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (±)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI)

Qu, Y., Chang, L., Klaff, J., Balbo, A., & Rapoport, S. I. (2003) · Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorPsychedelics and Drug Studies

Cited by 46

Therapeutic Targeting of Brain Arachidonic Acid Cascade in Bipolar Disorder by Low Dose Aspirin and Celecoxib

Rapoport, S. I., & Hibbeln, J. R. (2020) · Prostaglandins, Leukotrienes and Essential Fatty Acids

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 11